Projects related to 26-2006-467

Results found (16)
No.CategoryTechnology NameBriefcaseLead Researcher
2894
 About the company Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into thermogenic, brown-like adipose ...
More
Ben-Sasson Shmuel
3056
Computing Smart Peptides About us: Pepticom Ltd. is an Israeli innovative computational drug discovery company founded on December 2011, privately co-owned by the Hebrew University of Jerusalem, seed investors and the scientific team that ...
More
Goldblum Amiram
4370
Company Profile Splisense is developing targeted therapies for genetic diseases based on splicing modulation treating the underlying root cause of the disease.   SpliSense’s initial focus is on Cystic Fibrosis. SpliSense is developing a new ...
More
Kerem Batsheva
4402
Company Profile Tissue Dynamics Ltd. is a groundbreaking biotechnology company advancing smart microphysiological platforms for drug, food, and cosmetic development. The company’s proprietary tissue-embedded micro sensors permit real time ...
More
Nahmias Yaakov
4403
Company Profile OnTimeBio is a cross-indication liquid biopsy (blood test) used to identify disease before symptoms appear. It is valid for cancer, neurological, metabolic, autoimmune, inflammatory and cardiovascular diseases A liquid biopsy is ...
More
Dor Yuval
2565
Next-Generation Accelerators for Proton Beam Radiotherapy Investment/ Collaboration Opportunity Highlights: Investment round Strategic co-development opportunitiesAbout the company HIL Applied Medical is developing a new class of proton ...
More
Zigler Arie
3175
  Current CEO: Ariel Shrem About the Company Guide In Medical is a medical device company specializing in airway management and respiration. The company is ISO 13485 certified and received the CE Mark, FDA, Health Canada and Israeli marketing ...
More
Shrem Ariel
2918
At a Glance Ayana Pharma is uniquely positioned to expand the uses and efficacy of the lipid-based cytotoxic drug’s well-established clinical profile. Invented by Prof. Yechezkel Barenholtz from the Hebrew University who is also the co-founder ...
More
Barenholz Yechezkel
3184
Year Company was Founded 2015 Company Founder Prof Simon Benita Current CEO Alon Moran About the Company Based on decades of research by its founder and chairman, Prof. Simon Benita, a world-renowned scientist of nanotechnology, inventor of ...
More
Benita Simon
4528
  Company Founder Shuki Herchovici Current CEO Dr. Nikolai Kunicher About the Company Betalin Therapeutics is developing a revolutionary therapy for diabetes treatment. Our engineered micro pancreas (EMP) aims to replace insulin therapy for ...
More
Mitrani Eduardo
423
  About The Company Established in 2003 by Prof. Raymond Kaempfer and Dr. Gila Arad, AtoxBio is a late stage biotech company that develops novel immunomodulators for fighting infectious diseases by targeting the host immune system, rather than ...
More
Kaempfer Raymond
4361
The Challenge Drug resistance is a major cause for failure of cancer chemotherapy. In present clinical practice, resistance to chemotherapy can only be recognized after the first course of treatment has been completed, yielding no major clinical ...
More
Benvenisty Nissim
2652
Company Name LipoCure Year Company was founded 2009 Company Founders Prof. Yechezkel Barenholtz Current CEO Dr. Liana Patt, Ph. D., MBA About the Company LipoCure is developing a number of highly-potent therapeutics utilizing proprietary ...
More
Barenholz Yechezkel
3090
AT A GLANCE Established by Integra Holdings and XL Vision Sciences, fully owned by BioLight Lifesciences Investments, in 2014, OPhRx is developing novel drug products for topical administration for diseases involving front-of the eye and back of ...
More
Garti Nissim
4429
AT A GLANCE Established by Integra Holdings in 2017, Nectin Therapeutics is developing novel monoclonal antibodies directed towards Nectin receptors and ligands, playing major roles in immune checkpoint mechanisms relevant for cancer immune ...
More
Mandelboim Ofer
2792
Company Name LDS Lyotropic Delivery Systems Ltd. Company Founders Professor Nissim Garti  Current CEO Professor Nissim Garti  About the Company LDS is a privately owned nano and biotechnology company focusing on the development of novel liquid ...
More
Garti Nissim